Patents by Inventor Laura M. Gustavson

Laura M. Gustavson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190091481
    Abstract: A wearable cardioverter defibrillator (WCD) system includes a support structure that the patient may wear, and one or more sensors that may acquire patient physiological signals, such as ECG and others. A processor of the WCD system may determine diagnostics from the patient physiological signals. These diagnostics include a six-second ECG portion, heart rates as histograms, heart rates against QRS width, heart rate trends, clinical event counters, diagnostics relating to heart rate variability and about the atrial arrhythmia burden of the patient. In some embodiments, the WCD system includes a user interface with a screen that displays these diagnostics. In some embodiments, the WCD system exports these diagnostics for viewing by a different screen. When viewed, these diagnostics permit more detailed analysis of the state of the patient.
    Type: Application
    Filed: October 22, 2018
    Publication date: March 28, 2019
    Applicant: West Affum Holdings Corp.
    Inventors: Laura M. Gustavson, David P. Finch, Joseph L. Sullivan
  • Patent number: 10105547
    Abstract: A wearable cardioverter defibrillator (WCD) system includes a support structure that the patient may wear, and one or more sensors that may acquire patient physiological signals, such as ECG and others. A processor of the WCD system may determine diagnostics from the patient physiological signals. These diagnostics include a six-second ECG portion, heart rates as histograms, heart rates against QRS width, heart rate trends, clinical event counters, diagnostics relating to heart rate variability and about the atrial arrhythmia burden of the patient. In some embodiments, the WCD system includes a user interface with a screen that displays these diagnostics. In some embodiments, the WCD system exports these diagnostics for viewing by a different screen. When viewed, these diagnostics permit more detailed analysis of the state of the patient.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: October 23, 2018
    Inventors: Laura M. Gustavson, David P. Finch, Joseph L. Sullivan
  • Publication number: 20180185662
    Abstract: A wearable cardioverter defibrillator (WCD) having a processor configured to receive a signal indicating a position and/or movement of the ambulatory patient while the ambulatory patient is wearing the support structure receive the ECG signal, determine from an ECG signal whether a shock criterion is met, determine a confirmation time period and/or a response time period based on the position and/or movement of the ambulatory patient, determine from the ECG signal whether the shock criterion is met after the confirmation time period has elapsed, cause the user interface to generate the shock alert signal based on the shock criterion determined after the confirmation time period has elapsed, and control the discharge circuit to discharge the stored electrical charge when a predetermined time period has elapsed after the shock alert signal.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 5, 2018
    Inventors: Phillip D. Foshee, JR., David P. Finch, Pamela Breske, Laura M. Gustavson, Joseph L. Sullivan, Jaeho Kim
  • Publication number: 20180117299
    Abstract: A wearable cardioverter defibrillator (“WCD”) system may include an impedance detector configured to render an impedance signal of the patient. The WCD system may determine, from the impedance signal, a characteristic of breathing by the patient that can be used as a vital sign. The WCD system may determine, from at least the breathing characteristic, whether or not a shock criterion is met. If the shock criterion is met, the WCD system may control a discharge circuit to discharge a stored electrical charge through the patient. An advantage can be that the breathing characteristic may be used to determine whether or not a patient is experiencing a condition that requires defibrillation therapy, such as sudden cardiac arrest. Even more advantages can be had in discerning the state of the patient when the breathing characteristic is combined with other data, such as from a motion detector.
    Type: Application
    Filed: October 25, 2017
    Publication date: May 3, 2018
    Inventors: Laura M. Gustavson, Kenneth Frederick Cowan
  • Publication number: 20170368363
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system may output a closing human-perceptible indication, after detecting a shockable cardiac arrhythmia, and after further determining that it will not shock. This may succeed in informing the patient that the WCD system will not deliver a shock responsive to the cardiac arrhythmia, which may have just self-terminated. The information may give comfort to the patient who may be conscious, and may recognize that his or her ventricular tachycardia has self-terminated. Moreover, the patient will know that he or she will not be unnecessarily shocked while conscious, and will not even need to press a cancel switch.
    Type: Application
    Filed: August 9, 2017
    Publication date: December 28, 2017
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20170319862
    Abstract: A wearable cardioverter defibrillator (“WCD”) system may output a loud sound after detecting and validating a shockable cardiac arrhythmia. In such embodiments, however, the WCD system might not sound a loud alarm before validating the arrhythmia thoroughly, i.e. for a longer time, thus giving the arrhythmia a further chance to self-terminate. The WCD system may thus detect more robustly the cardiac arrhythmias that do not self-terminate quickly. Such arrhythmias that self-terminate quickly may occur from likely harmless events occurring multiple times in the daily life of the patient, such as the patient becoming “winded” from climbing stairs. In embodiments the WCD system may notify the patient only discreetly, or even not at all. The lack of sounding such a loud alarm responsive to such events reduces the overall number of times in which the patient experiences unwanted attention by others, embarrassment, loss of privacy and dignity, and so on.
    Type: Application
    Filed: July 12, 2017
    Publication date: November 9, 2017
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan
  • Patent number: 9757579
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system may output an opening human-perceptible indication, after detecting a shockable cardiac arrhythmia but before validating it. This may succeed in informing the patient that the WCD system is working, and in particular analyzing a just-detected cardiac arrhythmia. The information may give comfort and confidence to the patient who may be conscious, and be experiencing only ventricular tachycardia but not ventricular fibrillation.
    Type: Grant
    Filed: November 14, 2015
    Date of Patent: September 12, 2017
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20170128735
    Abstract: A wearable cardioverter defibrillator (WCD) system includes a support structure that the patient may wear, and one or more sensors that may acquire patient physiological signals, such as ECG and others. A processor of the WCD system may determine diagnostics from the patient physiological signals. These diagnostics include a six-second ECG portion, heart rates as histograms, heart rates against QRS width, heart rate trends, clinical event counters, diagnostics relating to heart rate variability and about the atrial arrhythmia burden of the patient. In some embodiments, the WCD system includes a user interface with a screen that displays these diagnostics. In some embodiments, the WCD system exports these diagnostics for viewing by a different screen. When viewed, these diagnostics permit more detailed analysis of the state of the patient.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 11, 2017
    Inventors: Laura M. Gustavson, David P. Finch, Joseph L. Sullivan
  • Publication number: 20160082277
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system may output an opening human-perceptible indication, after detecting a shockable cardiac arrhythmia but before validating it. This may succeed in informing the patient that the WCD system is working, and in particular analyzing a just-detected cardiac arrhythmia. The information may give comfort and confidence to the patient who may be conscious, and be experiencing only ventricular tachycardia but not ventricular fibrillation.
    Type: Application
    Filed: November 14, 2015
    Publication date: March 24, 2016
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Patent number: D764670
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: August 23, 2016
    Assignee: West Affum Holdings Corp.
    Inventors: David P. Finch, Phillip D. Foshee, Jr., Laura M. Gustavson, Robert R. Buchanan, Kenneth Cowan, Daniel J. Finney, Jason W. Fouts, Karen E. McEwen
  • Patent number: D825060
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: August 7, 2018
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: David P. Finch, Phillip D. Foshee, Jr., Laura M. Gustavson, Robert R. Buchanan, Kenneth Cowan, Daniel J. Finney, Jason W. Fouts, Karen E. McEwen